INTRODUCTION {#h0.0}
============

*Streptococcus agalactiae*, or group B *Streptococcus* (GBS), is a human pathogen that causes septicemia and meningitis in neonates ([@B1], [@B2]), and it is also a known cause of bovine mastitis ([@B3]). In this decade, GBS remains the dominant cause of infant morbidity and mortality in the United States ([@B4]), and it has also been recognized as an important cause of infections in immunocompromised patients and the elderly ([@B5]). GBS is a commensal in the rectovaginal tract of 20% to 30% of healthy women ([@B6]). However, by vertical transmission intrapartum, it may transition to an invasive pathogen, resulting in pneumonia, sepsis, and meningitis ([@B7]). The physiopathology of GBS infections implies that this bacterium encounters several very different microenvironments during colonization and the infectious process. The transition of the organism from a commensal niche (e.g., vaginal tract) to invasive niches (e.g., blood, lung, brain, and other organs) is likely to require adaptive changes, and a well-known way for bacteria to monitor and respond to their environment is by the use of two-component signal transduction systems (TCS).

TCS are typically organized in operons that encode a sensing histidine kinase (HK) and a response regulator (RR). The HK harbors an N-terminal input domain that recognizes a specific stimulus. The information is then transduced through intramolecular conformational changes, resulting in the phosphorylation and activation of the C-terminal transmitter domain. This domain, in turn, activates its cognate receiver, encoded by the N-terminal domain of the RR. Once activated, the RR gives rise to an intracellular response through the C-terminal effector (or output) domain. This response typically results in differential gene expression. Sequence homology is generally a poor predictor of sensing mechanisms or specific stimuli, while domain architecture may provide clues that assist in assigning HKs to one of three groups: extracellular sensing, membrane sensing, and cytoplasmic sensing ([@B8]).

Overall, the role of TCS in GBS pathogenesis is not well understood. The most studied system is CovRS, an important regulator in *Streptococcus* spp. In GBS, the CovRS regulon extends to 7% to 27% of the genome (depending on growth conditions) and includes different functional categories, such as cell envelope, cellular processes, metabolism, and virulence factors ([@B9][@B10][@B12]). The RRs CiaR ([@B13]), Sak189 ([@B14]), and LiaR ([@B15]) are reported to directly influence *in vivo* virulence in GBS. Moreover, the TCS DltRS ([@B16]) and RgfAC ([@B17], [@B18]) have been shown to affect gene expression in GBS.

In the present study, we aimed to better understand the role of TCS in GBS pathophysiology by adopting a stepwise screening strategy. First, inventory, comparative genomics analysis, and sensing mechanism classification were performed through a bioinformatics approach. Second, by transcriptional analysis and identification of output domains related to virulence, we selected five systems for further study. We generated TCS knockout mutants and analyzed their transcriptome *in vitro*, as well as their contribution to virulence and colonization *in vivo*. One TCS was further characterized, and we propose evidence for a specific stimulus-response circuit.

RESULTS {#h1}
=======

Identification and comparative genomics of TCS. {#h1.1}
-----------------------------------------------

For the purposes of our study, we focused our main attention on serotype V GBS isolates. Type V is the most common capsular serotype associated with invasive infection in nonpregnant adults and has increased among neonatal invasive disease strains in recent years, accounting for approximately one-third of clinical isolates in the U.S. population ([@B19]). To identify possible TCS, genes predicted to encode HKs or RRs in the GBS type V strain 2603 V/R genome were collected from the P2CS database (<http://www.p2cs.org>) ([@B20]) and the loci were compared with those in a second type V genome (strain CJB111). A total of 38 genes (21 systems) were identified ([Table 1](#tab1){ref-type="table"}). Seventeen of these loci contained a cognate pair of HK/RR-encoding genes, and an additional 4 TCS genes were orphans in strain 2603 V/R, while the corresponding numbers of cognate pairs and orphans in strain CJB111 were 19 and 2, respectively. Each TCS locus, whether paired or orphaned, was assigned a number in order of its appearance on the chromosome. The predicted TCS proteins were then used as queries to identify corresponding gene loci in 251 other GBS genomes (draft and complete), representing isolates from different host species (predominantly human and bovine). Overall, the 21 TCS were very well conserved (\>98% identity) across the genomes. Our analysis was unidirectional, and we do not exclude the presence of additional TCS. We have likely underestimated the number of fully functional orthologous systems, due to a number of TCS sequences being located in the vicinity of contig breaks. With the very limited variability observed in a large set of genomes, the TCS identified here appear to be part of the GBS core genome. TCS-17 (also known as RgfAC) presented an interesting case of variability. While TCS-17/RgfAC is complete and conserved in 64 strains, 118 strains have an orphan TCS-17/RgfAC where only the RR/RgfA is present, and another 61 strains had polymorphisms that inactivated the RR/RgfA. Moreover, orphaned and complete loci may represent two distinct families. While the protein sequence conservation is typically high (99% identity) when comparing RRs within a family (e.g., orphaned versus orphaned), a similar comparison across families shows a decreased sequence conservation (79% identity). Genomes with an orphan TCS-17 may have undergone recombinatorial events, as they show larger deletions in the locus with short remnants of putative *hk* or *rr* genes.

###### 

Comparative genomics of TCS

  TCS locus     Locus tag in 2603 V/R   Type   No. of strains with:   No. of proteins with:   Avg % identity (SD)   JCVI designation^[*f*](#ngtab1.1)^   Gene name(s) (reference)^[*g*](#ngtab1.2)^                             
  ------------- ----------------------- ------ ---------------------- ----------------------- --------------------- ------------------------------------ -------------------------------------------- --------------- --------- ----------------------------
  1             SAG0123                 RR     240                    4                       0                     9                                    6                                            99.02 (0.46)    SAM0116   
                SAG0124                 HK     246                    3                       0                     4                                    17                                           98.61 (0.58)    SAM0117   
  2             SAG0182                 HK     240                    3                       6                     4                                    21                                           99.53 (0.22)    SAM0183   
  SAG0183       RR                      248    3                      1                       1                     6                                    99.06 (0.48)                                 SAM0184                   
  3 (orphan)    SAG0310                 HK     198                    3                       12                    40                                   27                                           98.17 (3.32)    SAM0322   
                                        246    3                      2                       2                     30                                   97.87 (2.39)                                 SAM0323                   
  4             SAG0321                 HK     250                    3                       0                     0                                    9                                            99.28 (0.29)    SAM0333   *liaSR* ([@B15])
  SAG0322       RR                      248    3                      0                       2                     4                                    99.30 (0.25)                                 SAM0334                   
  5             SAG0393                 RR     242                    10                      0                     1                                    4                                            99.13 (0.39)    SAM0401   
  SAG0394       HK                      239    3                      1                       10                    11                                   99.36 (0.28)                                 SAM0402                   
  6             SAG0616                 RR     226                    26                      0                     1                                    2                                            99.54 (0.00)    SAM0583   *sak188*/*sak189* ([@B14])
  SAG0617       HK                      209    25                     4                       15                    11                                   97.23 (4.53)                                 SAM0584                   
  7 (orphan)    SAG0712                 RR     240                    2                       1                     10                                   7                                            99.11 (0.38)    SAM0733   
  8             SAG0719                 RR     241                    4                       7                     1                                    7                                            99.28 (0.19)    SAM0741   
  SAG0720       HK                      247    4                      1                       1                     16                                   99.53 (0.13)                                 SAM0742                   
  9             SAG0976                 RR     237                    4                       9                     3                                    12                                           98.86 (0.56)    SAM0983   
  SAG0977       HK                      247    4                      0                       2                     12                                   99.04 (0.41)                                 SAM0984                   
  10            SAG0984                 HK     250                    3                       0                     0                                    20                                           99.47 (0.18)    SAM0991   *ciaRH* ([@B13])
  SAG0985       RR                      250    3                      0                       0                     4                                    99.34 (0.24)                                 SAM0992                   
  11            SAG1016                 RR     248                    3                       1                     1                                    14                                           98.91 (0.45)    SAM1027   
  SAG1017       HK                      244    3                      1                       5                     25                                   99.12 (0.39)                                 SAM1028                   
  12            SAG1327                 HK     249                    3                       0                     1                                    15                                           99.27 (0.27)    SAM1289   
  SAG1328       RR                      248    3                      1                       1                     10                                   98.80 (0.65)                                 SAM1290                   
  13            SAG1624                 HK     249                    1                       1                     2                                    27                                           99.35 (0.38)    SAM1583   *covRS* ([@B10])
  SAG1625       RR                      252    1                      0                       0                     6                                    99.19 (0.32)                                 SAM1584                   
  14            SAG1791                 HK     244                    0                       3                     6                                    17                                           99.34 (0.23)    SAM1775   *dltRS* ([@B16])
  SAG1792       RR                      232    1                      17                      3                     15                                   98.70 (0.54)                                 SAM1776                   
  15 (orphan)   SAG1922                 RR     239                    5                       6                     3                                    8                                            99.54 (0.30)    SAM1860   
  16            SAG1946                 RR     248                    3                       1                     1                                    16                                           99.11 (0.28)    SAM1885   
  SAG1947       HK                      245    3                      3                       2                     27                                   99.12 (0.39)                                 SAM1886                   
  17 (orphan)                                  123                    128                     0                     2                                    8                                            88.26 (10.33)   SAM1896   *rgfAC* ([@B17])
  SAG1957       RR                      182    3                      61                      7                     12                                   98.71 (0.72)                                 SAM1897                   
  18            SAG1960                 HK     246                    4                       2                     1                                    23                                           99.10 (0.46)    SAM1900   
  SAG1961       RR                      239    4                      0                       10                    12                                   98.92 (0.42)                                 SAM1901                   
  19            SAG2054                 RR     249                    2                       1                     1                                    15                                           98.69 (0.60)    SAM1962   
  SAG2055       HK                      237    2                      7                       7                     21                                   99.14 (0.36)                                 SAM1963                   
  20            SAG2122                 RR     237                    14                      0                     2                                    14                                           98.85 (0.42)    SAM2038   
  SAG2123       HK                      236    13                     2                       2                     19                                   98.87 (0.61)                                 SAM2039                   
  21            SAG2127                 HK     228                    21                      0                     4                                    15                                           99.26 (0.30)    SAM2043   
  SAG2128       RR                      223    12                     6                       12                    3                                    99.52 (0.21)                                 SAM2044                   

Strains with putatively functional ortholog (i.e., \>75% identity for at least 90% of the query sequence).

Strains where no ortholog was identified.

Strains where proteins were truncated and possibly inactivated.

Proteins with nucleotide ambiguities or proximity to contig break.

Distinct variant proteins.

J. Craig Venter Institute (formerly TIGR) gene names of *hk* and *rr* genes in the CJB111 strain used in the experimental studies.

Previously reported gene name and citation.

A minimum spanning tree (MST) using the 40 TCS genes and all their respective variants was created to identify potential TCS profile clusters ([Fig. 1](#fig1){ref-type="fig"}). Interestingly, bovine isolates appeared to contain TCS profiles that clustered together and were relatively more distant from human isolates. TCS-17 again constituted a particular example in which RR variants appeared to group according to the host species from which they were isolated (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material). Variant 2 was found in 43% of bovine strains versus 6% of human strains. Conversely, variant 4 was found in 41% of human strains and only 13% of bovine strains.

![Minimum spanning tree (MST), obtained using the goeBurst algorithm and based on the TCS protein similarity in 253 GBS genomes. Isolates are from different hosts, as indicated, and each node represents a TCS profile. The sizes of the nodes are proportional to the numbers of isolates with each profile.](mbo0031418300001){#fig1}

Domain architecture for TCS in the genome of CJB111. {#h1.2}
----------------------------------------------------

For further experimental analysis, we shifted our focus to the serotype V strain CJB111, which is more virulent than 2603 V/R in mouse models and for which a custom microarray was available in-house. The CJB111 TCS gene identifiers are listed in [Table 1](#tab1){ref-type="table"}. We analyzed the domain architecture of all the HK proteins in the genome of CJB111 and predicted the mechanism of stimulus perception according to criteria reported in the literature ([@B8]) ([Fig. 2](#fig2){ref-type="fig"}). Nine of the HKs contained an N-terminal domain with two transmembrane helices with a spacer of 50 to 300 amino acids, typical for extracellular (EX) sensing. Eight HKs contained 2 to 6 predicted transmembrane-spanning regions separated by short spacers and were predicted to be membrane sensing (TM). Only one HK was classified as cytoplasmic (C) sensing.

![Domain architecture of histidine kinases. Protein sequences were analyzed using SMART <http://smart.embl-heidelberg.de>, and PFAM domains were included. The scale bar shows the sequence length in amino acids. Blue vertical bars represent putative transmembrane helices, and pink squares represent low-complexity regions. Various functional domains are indicated by the remaining colored elements and using the SMART nomenclature (e.g., GAF, PAS, HAMP, PAC). The SMART HATPase_c domain in TCS-17/RgfAC is an outlier homolog and was found by using the schnipsel database. Sensing mechanisms were manually predicted as transmembrane (TM), extracellular (EX), and cytoplasmic (C).](mbo0031418300002){#fig2}

We also observed that all the RR proteins had a DNA binding output domain, indicating a role as direct transcriptional regulators. Interestingly, the LytTR output domain was the second most common output domain in GBS (15%), while it accounts for a smaller percentage (4%) in prokaryotes in general. LytTR-type output domains have been noted for the control of virulence factors in several important bacterial pathogens ([@B20]).

Transcriptional analysis of TCS. {#h1.3}
--------------------------------

Transcriptional analysis was performed in early logarithmic (EL) and early stationary (ES) phase using a custom microarray chip designed on the CJB111 genome. We noted that several TCS were significantly upregulated in ES phase, and 3 of these (TCS-2, TCS-16, and TCS-21) were upregulated 4-fold or more. As many TCS respond to stress conditions like those encountered in stationary phase (lack of nutrients, low pH, and accumulation of toxic metabolites), we hypothesized that these systems could be involved in bacterial stress responses and selected them as targets for mutagenesis. To further understand the levels of expression of each selected TCS during bacterial growth *in vitro*, we measured the gene transcripts of the HKs at four time points (representing early, mid-, and late logarithmic and early stationary phases) using a real-time quantitative (qRT)-PCR analysis (see [Fig. S2](#figS2){ref-type="supplementary-material"} in the supplemental material). These data confirmed that TCS-2, TCS-16, and TCS-21 are upregulated only in ES phase.

Transcriptional regulators with the LytTR-type output domains control the production of virulence factors in several important bacterial pathogens ([@B20]). We therefore selected as mutagenesis targets the three TCS containing an RR with a LytTR-type DNA binding domain, i.e., TCS-2 (upregulated at ES phase), TCS-11, and TCS-17/RgfAC. Thus, a total of five TCS exhibiting either the presence of a LytTR domain and/or upregulation during ES were selected for further experimentation ([Table 2](#tab2){ref-type="table"}).

###### 

CJB111 expression of selected TCS

  TCS locus   Locus tag              Type                   Fold change^[*a*](#ngtab2.1)^   *P* value^[*b*](#ngtab2.2)^
  ----------- ---------------------- ---------------------- ------------------------------- -----------------------------
  2           SAM0183                HK                     6.1                             7.4 × 10^−4^
  SAM0184     RR^[*c*](#ngtab2.3)^   5.6                    6.0 × 10^−3^                    
  11          SAM1027                RR^[*c*](#ngtab2.3)^   0.9                             NS
  SAM1028     HK                     1.5                    NS                              
  16          SAM1885                RR                     4.5                             3.8 × 10^−3^
  SAM1886     HK                     5.5                    1.1 × 10^−3^                    
  17          SAM1896                HK                     1.1                             NS
  SAM1897     RR^[*c*](#ngtab2.3)^   1.6                    NS                              
  21          SAM2043                HK                     37.0                            6.0 × 10^−8^
  SAM2044     RR                     19.5                   6.3 × 10^−5^                    

Relative expression of the TCS in ES compared to EL growth phase.

NS, the fold change was considered not significant if the *P* value was \>0.05.

Contains a LytTR output domain.

Expression microarray analysis of TCS mutants. {#h1.4}
----------------------------------------------

The 5 selected TCS loci were modified genetically by in-frame deletion of the genes encoding RRs. There were no apparent differences in colony size, hemolysis, or other macroscopic features between the wild-type (WT) strain and the five isogenic mutant strains on blood agar or tryptic soy agar plates (data not shown). Mutant strains grown in complex medium exhibited growth curves identical to that of the wild-type parental strain (see [Fig. S3](#figS3){ref-type="supplementary-material"} in the supplemental material).

Global transcriptional analysis was performed by microarray technology. Gene expression of all of the predicted genes (*n* = 2,232) in the CJB111 genome was performed by comparing the WT strain with each of the five mutant strains in ES phase ([Fig. 3A](#fig3){ref-type="fig"}). Experimental design, chip validation, quality control, and data analysis were performed as described in Materials and Methods. Further validation of the microarray data was performed by qRT-PCR, using probes for 9 independent transcriptional units (see [Fig. S4](#figS4){ref-type="supplementary-material"} in the supplemental material). Overall, all five mutants exhibited differential transcription of genes in comparison to the gene transcription in the wild type when using a permissive threshold (±2-fold change and a *P* value of \<0.05). The number of regulated genes ranged from 2 (Δ*rr17* strain; see Materials and Methods) to 66 (Δ*rr11* strain). Two mutants (the Δ*rr11* and Δ*rr21* strains) showed predominantly downregulated genes, suggesting that these RRs act as activators. We observed that some genes appeared to be regulated in two or more independent mutant strains ([Fig. 3B](#fig3){ref-type="fig"}). In particular, 20 genes were regulated in both the Δ*rr21* and the Δ*rr11* strain (19 genes downregulated and 1 gene upregulated in both strains).

![Microarray analysis of TCS mutant strains. (A) Bars represent the numbers of genes up- or downregulated in early stationary (ES) phase compared to their transcription in the WT strain. The threshold used is ±2-fold change and a *P* value of ≤0.05. (B) Venn diagram showing overlaps of gene regulation between the mutants. The fields show the number of individual genes significantly regulated in single or multiple mutant strains.](mbo0031418300003){#fig3}

A more stringent threshold was applied to identify the most highly regulated genes (±4-fold change and a *P* value of \<0.05). Three mutants (Δ*rr2*, Δ*rr11*, and Δ*rr16* strains) showed a total of 18 highly regulated genes, and in two of them, such genes were identified adjacent to the TCS locus ([Table 3](#tab3){ref-type="table"}). In particular, the Δ*rr2* mutant exhibited downregulation of SAM0185 and SAM0186, encoding two proteins similar to LrgAB in *Streptococcus mutans*. In this species, LrgAB is reported to be under the control of an adjacent TCS (homologous to TCS-2) and was suggested to have a role in the control of virulence and biofilm formation ([@B21], [@B22]). The Δ*rr16* mutant showed strong downregulation of an adjacent phosphotransferase system (PTS) and concomitant upregulation of another PTS system in a different locus. All of the highly regulated genes were subjected to confirmation by qRT-PCR, using one probe set per transcriptional unit ([Table 3](#tab3){ref-type="table"}). Moreover, qRT-PCR experiments were repeated on chromosomally complemented strains where the deleted *rr* gene was replaced with the WT form, which confirmed that the WT phenotype was restored ([Table 3](#tab3){ref-type="table"}).

###### 

Highly regulated genes in early stationary phase

  Mutation   Locus tag   Annotation                                       Gene       Fold change in microarray   *P* value^[*a*](#ngtab3.1)^   KO strain/KI strain fold changes in qRT-PCR^[*b*](#ngtab3.2)^
  ---------- ----------- ------------------------------------------------ ---------- --------------------------- ----------------------------- ---------------------------------------------------------------
  Δ*rr2*     SAM0185     LrgA family subfamily, putative                  *lrgA*     −11.5                       4.0 × 10^−5^                  −6.14/−1.18
             SAM0186     LrgB family protein                              *lrgB*     −8.8                        1.2 × 10^−4^                  
  Δ*rr11*    SAM0011     Phosphoribosylformyl-glycinamidine synthase                 −4.0                        2.2 × 10^−4^                  
             SAM0012     Amidophosphoribosyl-transferase                  *purF*     −4.0                        3.0 × 10^−3^                  −2.23/+2.98
             SAM0013     Phosphoribosylformyl-glycinamidine cycloligase   *purM*     −4.3                        2.4 × 10^−4^                  
             SAM0014     Phosphoribosylglycinamide formyltransferase      *purN*     −4.3                        1.8 × 10^−3^                  
             SAM0064     Ribosomal protein S5                             *rpsE*     −4.4                        1.8 × 10^−5^                  −2.01/+1.56
             SAM1026     Carbon starvation protein, putative              *cstA*     −5.7                        1.6 × 10^−5^                  −10.95/+2.11
             SAM1057     Conserved hypothetical protein                              −5.1                        1.8 × 10^−5^                  
             SAM1058     Conserved hypothetical protein                              −5.2                        5.8 × 10^−7^                  
             SAM1059     Carbamoyl-phosphate synthase, large subunit      *carB*     −7.4                        3.0 × 10^−7^                  −4.72/−1.69
             SAM1060     Carbamoyl-phosphate synthase, small subunit      *carA*     −4.2                        4.2 × 10^−2^                  
  Δ*rr16*    SAM1715     PTS system, IIC component                        *fruA-2*   +4.0                        1.4 × 10^−4^                  +3.25/−1.06
             SAM1716     PTS system, IIA component                        *fruA-2*   +4.1                        2.6 × 10^−4^                  
             SAM1887     PTS system, IID component                                   −31.6                       1.6 × 10^−7^                  −324.0/+1.72
             SAM1888     PTS system, IIC component                                   −72.0                       1.0 × 10^−7^                  
             SAM1889     PTS system, IIB component                                   −55.7                       1.0 × 10^−6^                  −6.14/−1.18
             SAM1890     PTS system, IIA component, putative                         −52.0                       1.8 × 10^−7^                  

Inclusion threshold is a *P* value of ≤0.05 and fold change of ±4 compared to the WT strain).

Fold changes in knockout/complemented strains compared to the WT strain.

Phenotype microarray screening shows that TCS-16 influences carbon source utilization. {#h1.5}
--------------------------------------------------------------------------------------

Our microarray analysis showed differential regulation of two different PTS (SAM1715 to SAM1716 and SAM1887 to SAM1890) in the Δ*rr16* mutant strain, suggesting a possible involvement in the monitoring of carbon source availability. The WT and Δ*rr16* strains were grown on 192 different single carbon sources using the phenotype microarray (PM) technology (see [Fig. S5](#figS5){ref-type="supplementary-material"} in the supplemental material). One compound showed a clear difference between the WT and mutant strain. The WT strain exhibited growth comparable to that of the positive control when supplied with fructose-6-phosphate (Fru-6-P), while the Δ*rr16* strain showed no growth. The experiment was repeated using the complemented (knock-in \[KI\]) KI*rr16* strain, which showed a growth profile indistinguishable from that of the WT strain ([Fig. S5](#figS5){ref-type="supplementary-material"}).

To confirm this phenotype in an independent system and to understand if it could be extended to other hexose-6-phosphate sugars, we used a chemically defined medium (CDM) ([@B23]) where glucose, fructose, mannose, or the corresponding hexose-6-phosphate counterpart of each was used as the primary carbon source ([Fig. 4](#fig4){ref-type="fig"}). The WT, Δ*rr16*, and KI*rr16* strains grew well on glucose, fructose, and mannose, while only the WT and KI*rr16* strains grew on Fru-6-P. The other phospho-sugars did not allow any bacterial growth. We concluded that TCS-16 is necessary for the growth of strain CJB111 on Fru-6-P as the primary carbon source.

![Growth curves of WT (blue), Δ*rr16* (red), and KI*rr16* (green) strains in CDM supplemented with 10 mg/ml of glucose or glucose-6-phosphate, fructose or fructose-6-phosphate, or mannose or mannose-6-phosphate. Growth curves are from triplicate samples, and the background (negative control, no sugar added) was subtracted.](mbo0031418300004){#fig4}

TCS-16 gene regulation in response to extracellular Fru-6-P. {#h1.6}
------------------------------------------------------------

We subsequently investigated the impact of Fru-6-P on the transcription of TCS-16 and its adjacent PTS system by using qRT-PCR. Bacteria grown in CDM were subjected to a substitution of glucose for Fru-6-P upon entry into mid-logarithmic phase (see Materials and Methods). Compared to its transcription in bacteria exposed to glucose, the transcription of the *hk16* gene increased 22-fold when bacteria were exposed to Fru-6-P ([Fig. 5A](#fig5){ref-type="fig"}). This response was observed in the WT, absent in the Δ*rr16* strain, and partially restored in the complemented KI*rr16* strain. Concomitantly ([Fig. 5B and C](#fig5){ref-type="fig"}), a similar pattern was observed for the adjacent PTS system (3,000-fold upregulation) and for the SAM1402 gene (2.5-fold upregulation), a putative hexose-6-P transporter gene that we identified in the genome of CJB111. A down-regulation of the SAM1402 gene (1.5-fold) in the Δ*rr16* strain was also observed in the microarray.

![Results of qRT-PCR with probes for SAM1885 (HK) (A, D), SAM1888 (PTS, IIC component) (B, E), and SAM1402 (putative hexose-phosphate transporter) (C, F) using RNA extracted from WT, Δ*rr16*, and KI*rr16* strains. (A to C) Bacteria grown in CDM were subjected to a pulse of either glucose (Glc) or fructose-6-phosphate (Fru-6-P) as the main carbon source for 30 min prior to RNA extraction. Bars represent gene expression when exposed to Fru-6-P relative to gene expression during growth in glucose. (D to F) Bacteria grown in CDM were subjected to a pulse of PBS or bacterial lysate for 30 min prior to RNA extraction. Bars represent gene expression when cells were exposed to bacterial lysate relative to gene expression in the PBS control. The experiment was performed twice. Bars represent technical triplicates, and error bars show the standard errors of the means.](mbo0031418300005){#fig5}

Fru-6-P is an intracellular metabolic intermediary of the glycolytic pathway. Bacterial lysis constitutes a possible scenario where Fru-6-P would be found in the extracellular space. We wanted to investigate whether TCS16 would respond under such conditions. Bacteria were grown in CDM until mid-logarithmic phase, and the medium was changed to CDM without glucose in the presence or absence of bacterial lysate (see Materials and Methods). The transcriptional levels of TCS-16, its adjacent PTS system, and the putative hexose-6-P transporter were then analyzed by qRT-PCR. The *hk16* gene transcription increased 10-fold when bacteria were exposed to bacterial lysate compared to its transcription in the control ([Fig. 5D](#fig5){ref-type="fig"}). Concomitantly, an upregulation of the PTS system (200-fold) and the SAM1402 gene (5-fold) was observed ([Fig. 5E and F](#fig5){ref-type="fig"}). These responses were absent in the Δ*rr16* strain and totally restored in the complemented KI*rr16* strain.

TCS-16 influences vaginal persistence in mice. {#h1.7}
----------------------------------------------

In a recent work, carbon catabolite repression in *Streptococcus pyogenes* was shown to influence asymptomatic colonization of the murine vaginal mucosa, suggesting that the availability of carbon sources may be subject to monitoring by the bacteria ([@B24]). We subsequently investigated whether TCS-16 could play a role in bacterial survival during colonization, utilizing the Δ*rr16* mutant strain in a mouse model of GBS vaginal colonization ([@B25], [@B26]). CD-1 mice in estrus were inoculated with \~1 × 10^7^ CFU in the vaginal lumen and, on successive days, bacteria were recovered by swabbing and quantified by serial dilution and plating on selective medium. Interestingly, the Δ*rr16* mutant exhibited decreased persistence in the vaginal tract ([Fig. 6](#fig6){ref-type="fig"}). The statistically significant differences were observed at later time points during the experiment (*P* = 0.004, day 5; *P* = 0.02, day 7) and suggested a gradual decline in colonization with the mutant strain, while the WT remained relatively stable throughout the experiment. Identical experiments were performed with the remaining mutant strains, and the results were similar to those with the WT strain, underlining that the phenotype seen in the Δ*rr16* mutant was unique among the strains tested.

![Murine vaginal colonization model. The vaginal lumen of CD-1 mice was inoculated with 10^7^ CFU of WT or Δ*rr16* bacteria, and bacterial persistence was determined by counting viable cells. Results shown are from two independent experiments. The detection limit is represented by the dashed line. Horizontal bars represent medians, and the Mann-Whitney *U* test was used for statistical analysis. \*, *P* \< 0.05; \*\*, *P* \< 0.005.](mbo0031418300006){#fig6}

TCS-17/RgfAC influences virulence in a murine model of systemic infection. {#h1.8}
--------------------------------------------------------------------------

To further investigate the role of the selected TCS in GBS pathogenesis, we compared the relative levels of virulence of CJB111 and the Δ*rr* mutants using an *in vivo* mouse model of infection ([@B27], [@B28]). CD-1 mice were infected intravenously with 1.5 × 10^7^ CFU of the WT or mutant strains. Bacteremia was confirmed in all mice by counting viable cells in blood samples collected 24 h postinfection, and there was no significant difference in bacterial loads between the WT and mutant strains (data not shown). Over the course of infection, animals were sacrificed at individual endpoints (when moribund) or upon termination of the experiments, and blood, brain, and lung tissues were collected for bacterial counts. Overall, the only mutant strain with a virulence phenotype was the Δ*rr17* strain, infection with which exhibited a significantly higher mortality than was observed during infection with the WT strain (*P* = 0.003, log-rank test) ([Fig. 7A](#fig7){ref-type="fig"}). Interestingly, no significant differences were observed in bacterial loads in brain, blood, and lung tissues when comparing the WT and Δ*rr17* strains ([Fig. 7B to D](#fig7){ref-type="fig"}). Blood and brain tissues from mice infected with the Δ*rr17* strain contained more individual samples with very high bacterial counts, but such samples were exclusively from moribund mice ([Fig. 7B and C](#fig7){ref-type="fig"}). None of the other mutant strains showed an appreciable difference from the WT strain (data not shown).

![Murine intravenous challenge model. (A) Kaplan-Meyer survival plot of mice infected with 1.5 × 10^7^ CFU of bacteria. The log-rank test was used for statistical analysis. (B to D) Bacterial counts (CFU) in blood, brain, and lung tissues from individual mice. Horizontal bars represent medians. Mice were euthanized when moribund (red) or at the end of the experiment (black).](mbo0031418300007){#fig7}

DISCUSSION {#h2}
==========

In the present study, we conducted genome-wide inventory, classification, and comparative genomics of TCS in GBS and concluded that they are highly conserved and part of the core genome. Nonetheless, the profile of TCS allelic variants differed somewhat when comparing human GBS isolates with those from bovine and other hosts. In our classification of sensing mechanisms, only one HK was classified as cytoplasmic sensing, while this is typically a more frequent category ([@B8]). A comparison of the number of TCS (corrected for genome size) in various pathogenic and nonpathogenic *Lactobacillales* spp. was also performed. In the nine species examined, GBS and *S. pyogenes* showed the highest frequencies of TCS, with medians of 38 and 36 TCS components, respectively (data not shown), compared to a typical range of 15 to 32 for the other *Lactobacillales*. This suggests that the two pathogens may require particular fine tuning of transcription in response to changing environments.

Transcriptome analysis was performed on five selected systems, and we observed a limited number of genes that were highly regulated for three TCS. TCS-2 regulates the adjacent *lrgAB* operon, similar to what has been described for *S. mutans* ([@B22]). TCS-11 regulates genes involved in purine metabolism and carbon starvation. TCS-16 highly regulates two PTS operons and is discussed in more detail below.

TCS-17/RgfAC has already been described in GBS strain O90-R, where it negatively regulates the transcription of C5a peptidase (*scpB*), a known virulence factor ([@B17]). Moreover, an independent group demonstrated that in clonal complex 17 (CC17) strains, RgfAC negatively regulates the *fbsA* gene, encoding fibrinogen binding proteins ([@B18]). FbsA may have a role in protecting the bacteria against opsonophagocytosis, promoting adhesion to lung epithelial cells, and increasing survival in human blood ([@B29], [@B30]). We did not observe any upregulation of the above-described genes in the Δ*rr17* strain, which may be due to differences in the experimental protocol (time points) or in the genetic background (CJB111 belongs to CC1 \[[@B31]\]). Nonetheless, the Δ*rr17* strain was hypervirulent in our murine model of systemic infection, consistent with a potential upregulation of virulence factors in the absence of this transcriptional regulator. TCS-17 was also the only system where specific allelic variants were distributed differently between human and bovine isolates, suggesting a potential host-specific role during infection.

The second system of particular interest was TCS-16. Transcriptome analysis showed prominent downregulation of an adjacent operon that encodes a putative PTS (Man/Fru/Sor family) and concomitant upregulation of another PTS (Fru family). TCS-16 was classified as an extracellular sensing system, and we hypothesized that it may be involved in monitoring and responding to the availability of nutrients ([@B8]). When bacteria were subjected to a large variety of different carbon sources in chemically defined medium, one compound, Fru-6-P, resulted in a complete growth defect, which was fully restored when the Δ*rr16* mutation was complemented. Further experiments *in vitro*, using phosphorylated and nonphosphorylated hexose sugars, confirmed these results. We thus conclude that a functional TCS-16 is necessary for growth on Fru-6-P. Investigation of the transcriptional events in the locus showed that, upon exposure to extracellular Fru-6-P, there is induction of TCS-16 and a concomitant drastic upregulation of the adjacent PTS operon. As the Δ*rr16* strain showed no such response, while the complemented strain exhibited a partial restoration, we conclude that a functional TCS-16 is necessary for autoinduction and regulation of the adjacent PTS operon. We propose that extracellular Fru-6-P is a signal for TCS-16 and that the gene locus be named *fspSR*, for [f]{.ul}ructose-[s]{.ul}ix-[p]{.ul}hosphate [s]{.ul}ensor histidine kinase and [r]{.ul}esponse regulator. Despite the magnitude of the influence on PTS transcription, the growth defect observed in the Δ*rr16* (Δ*fspR*) strain is difficult to explain in terms of a direct link between the upregulated PTS and the utilization of Fru-6-P as an energy source. To our knowledge, PTS-dependent import of phosphorylated sugars has not been described. However, other such uptake mechanisms are known, and UhpT (major facilitator superfamily) in *Escherichia coli* represents an example where the controlling TCS (UhpAB) is necessary for the growth of *E. coli* upon Glc-6-P and Fru-6-P ([@B32], [@B33]). We identified a homologue of UhpT in the genome of CJB111 (SAM1402), and analysis of the protein suggests it could function as a hexose-6-P transporter (<http://www.tcdb.org/>). SAM1402 was among the genes significantly downregulated in the Δ*rr16* (Δ*fspR*) mutant transcriptome, and subsequent experiments confirmed that TCS-16/FspSR upregulates the SAM1402 gene in response to extracellular Fru-6-P. The biological relevance of our link between Fru-6-P and TCS-16/FspSR is difficult to ascertain, as the availability of Fru-6-P in the extracellular milieu is presumably limited or unknown. Nevertheless, our *in vivo* screening showed reduced vaginal persistence of the Δ*rr16* (Δ*fspR*) strain in mice. The PTS and associated carbon metabolism pathways may have an impact on *in vivo* fitness and virulence, as previously demonstrated for several different pathogens ([@B34][@B35][@B38]). One possibility is that Fru-6-P may be released from dying microorganisms in the complex microbiota of the vagina or in stationary-phase *in vitro* cultures, and GBS could consequently initiate a scavenging response involving upregulation of sugar transporters. This hypothesis was supported by our data showing that there is an induction of the TCS-16 response upon exposure to bacterial lysate. This response was observed in the WT and complemented strains but not in the Δ*rr16* (Δ*fspR*) strain, confirming that a functional TCS-16 is necessary to upregulate sugar transporters in the presence of lysed GBS components. Moreover, in a previous work using a different strain, the PTS operon described above, together with several other PTS, were highly downregulated under high-glucose conditions, supporting a role for this and similar systems under conditions where nutrients are relatively scarce ([@B12]). Another speculative possibility is that FspSR may be activated upon entry/invasion of eukaryotic cells, through the presence of Fru-6-P as a central metabolite in glycolysis.

We have listed and classified TCS in GBS for further study and conclude that these TCS are very well-conserved intraspecies but with allelic profiles that vary somewhat according to the host. Our results provide new insights into four previously unknown TCS but also provide the first *in vivo* data supporting a role for RgfAC in virulence. Finally we identified FspRS, a new TCS that is involved in vaginal persistence and responds to fructose-6-phosphate by the upregulation of genes involved in sugar transport.

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains and growth conditions. {#h3.1}
----------------------------------------

GBS strain CJB111 (Carol Baker Collection, Division of Infectious Diseases, Baylor College of Medicine, Houston, TX) and its isogenic derivatives were grown in Todd-Hewitt broth (THB medium; Difco Laboratories) at 37°C, 5% CO~2~. Tryptic soy broth (Difco Laboratories) with 15 g/liter agar (TSA) was used as the solid medium. Max Efficiency DH5α competent *E. coli* cells (Invitrogen) were used for transformation, propagation, and preparation of plasmids. *E. coli* was grown at 37°C with agitation (180 rpm) in Luria-Bertani (LB; Difco Laboratories) broth or on 15 g/liter agar plates (LBA). Erythromycin (Erm) was used for selection of GBS (1 µg/ml) or *E. coli* (100 µg/ml) cells containing the pJRS233-derived plasmids used for mutagenesis (see below).

Strains CJB111, CJB111Δ*rr16*, and CJB111KI*rr16* were also grown in chemically defined medium (CDM) ([@B23]) or in CDM where glucose was replaced with 10 g/liter glucose-6-phosphate, fructose, fructose-6-phosphate, mannose, or mannose-6-phosphate (Sigma). Briefly, bacteria grown on THB plates were suspended in 5 ml of phosphate-buffered saline (PBS) until the optical density at 600 nm (OD~600~) reached 0.3. Samples were then diluted 1:10 in PBS, and 88 µl of bacteria was added to 1.2 ml of medium with or without different carbon sources. Bacteria were grown in 96-well plates with 200 µl per well for 48 h at 37°C, and the OD~600~ was monitored automatically every 20 min in an automated reader (Sunrise; Tecan).

Construction of TCS isogenic mutants. {#h3.2}
-------------------------------------

To construct the knockout strains, a pJRS233 shuttle vector ([@B39]) containing each TCS locus with an in-frame deletion in the response regulator gene (*rr*) was constructed using a splicing by overlap extension PCR (SOEing-PCR) strategy (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material) ([@B40]). Briefly, the up- and downstream regions of an *rr* gene were produced from CJB111 genomic DNA and then joined. The resulting fragment was cloned into pJRS233 using BamHI and XhoI restriction sites.

Five plasmids, pJRS233Δ*rr2*, pJRS233Δ*rr11*, pJRS233Δ*rr16*, pJRS233Δ*rr17*, and pJRS233Δ*rr21*, were obtained, each containing an insert with 700 to 800 bp upstream and downstream from the in-frame-deleted *rr* gene. The CJB111 genes thus inactivated were SAM0184 (*rr2*), SAM1027 (*rr11*), SAM1885 (*rr16*), SAM1897 (*rr17*), and SAM2044 (*rr21*).

To construct the respective chromosomally complemented knock-in (KI) strains, each wild-type locus was amplified and cloned into pJRS233 using BamHI and XhoI restriction sites (see [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material). These plasmids were designated pJRS233KI*rr2*, pJRS233KI*rr11*, pJRS233KI*rr16*, pJRS233KI*rr17*, and pJRS233KI*rr21*.

An insertion/duplication and excision mutagenesis strategy was used to obtain either the in-frame deletions in the response regulator genes or the chromosomal replacements in the knockout mutants. In brief, pJRS233Δ*rr2*, -Δ*rr11*, -Δ*rr16*, -Δ*rr17*, and -Δ*rr21* plasmids purified from *E. coli* were used to transform CJB111 by electroporation, as previously described ([@B41]), except that we used M9 medium without glycine and Casamino acids. Transformants were selected by growth on TSA containing Erm at 30°C for 48 h. Integration was performed by growth of transformants at 37°C (nonpermissive temperature for the suicide shuttle vector) with Erm selection. Excision of the integrated plasmid was performed by serial passages in THB at 30°C and parallel screening for Erm-sensitive colonies on plates. Mutants were verified by PCR sequencing of the TCS loci. We obtained thus five knockout strains, each having had the response regulator gene of a specific TCS inactivated, which we designated CJB111Δ*rr2*, CJB111Δ*rr11*, CJB111Δ*rr16*, CJB111Δ*rr17*, and CJB111Δ*rr21*, abbreviated herein as the Δ*rr2* strain, Δ*rr11* strain, etc.

To obtain the chromosomally complemented strains, plasmids PJRS233KI*rr2*, -KI*rr11*, -KI*rr16*, -KI*rr17*, and -KI*rr21* were purified from *E. coli* and complementation of the respective mutant strains was performed as described above. The result was replacement of the deleted *rr* gene with the WT form. The complemented strains were designated CJB111KI*rr2*, CJB111KI*rr11*, CJB111KI*rr16*, CJB111KI*rr17*, and CJB111KI*rr21*, abbreviated herein as the KIΔ*rr2* strain, KI*rr11* strain, etc.

Bioinformatics methods. {#h3.3}
-----------------------

The identification of histidine kinases (HKs) and response regulators (RRs) of putative TCS in the genome of GBS strain 2603 V/R was carried out using the P2CS (<http://www.p2cs.org>) database ([@B42]). A TCS was defined as an orphan if the predicted HK or RR gene had no adjacent partner in the locus or if the cognate partner contained any mutations (e.g., stop codons or frameshifts) that compromised the predicted gene product.

Gene sequences encoding the TCS were downloaded from the publically available genome of 2603 V/R in GenBank, except for the RR from TCS-3 and HK from TCS-17, which were downloaded from the publically available genome of CJB111. The genes used are listed in [Table 1](#tab1){ref-type="table"}. All gene sequences were aligned against complete or draft genome sequences using FASTA version 3.4t25. A gene was considered present if the identity was \>75% on at least 90% of the query sequence. Genes interrupted at the end of contigs, alignments with over 95% identity on less than 40% of the query length, and hits divided into pieces on the same contig were classified as having "ambiguity in alignment."

For polypeptide analyses, all of the genes were translated into proteins and those having mutations leading to truncated proteins were discarded. A numeric identifier was assigned to each different putatively active polypeptide for each gene. For each strain, a polypeptide profile of TCS was created. The goeBurst algorithm ([@B43]) was used to generate a minimum spanning tree (MST) from the profiles using Phyloviz ([@B44]). In this tree, each vertex represents a specific profile and each edge connects the profile to its closest ones.

Functional domains in each HK protein were identified by SMART and/or PFAM (<http://smart.embl-heidelberg.de>). Subsequently, HKs were manually assigned a signaling mechanism according to proposed criteria ([@B8]). Extracellular-sensing HKs typically have two TM helices with an intervening extracytoplasmic domain of 50 to 300 amino acids, lacking large cytoplasmic linker regions; transmembrane-sensing HKs are characterized by the presence of 2 to 20 transmembrane regions connected by very short intra- or extracellular linkers; cytoplasmic-sensing HKs include either membrane-anchored proteins that do not fulfill the criteria described above and have input domains (e.g., PAS, GAF) localized on the intracellular side or soluble HKs with no transmembrane regions.

Expression microarray analysis. {#h3.4}
-------------------------------

Expression microarray analysis was performed using a custom-made Agilent 60-mer oligonucleotide microarray. Oligonucleotide sequences were selected with the Agilent eArray system, using 6 probes per gene. The complete set of annotated genes (2,232) in the CJB111 genome was thus covered (<ftp://ftp.jcvi.org/pub/data/Microbial_Genomes/s_agalatiae_cjb111/>). RNA samples used for microarray analysis were prepared as follows. Bacteria for RNA extraction (five mutant strains and the isogenic WT strain) were grown in triplicate cultures on three separate occasions. Hence, for each strain, nine independent GBS cultures (nine biological replicates obtained on three separate days) served as the source of RNA. Bacteria were harvested twice, at an OD~600~ of 0.3 (EL phase) and an OD~600~ of 1.8 to 1.9 (ES phase, \~15 min into growth arrest). To rapidly arrest transcription, 10 ml of bacteria was cooled on ice and added to 10 ml of frozen THB medium in a 50-ml conical tube. GBS cells were then collected by centrifugation for 15 min at 4,000 rpm, 4°C, and resuspended in 800 µl of TRIzol (Invitrogen). Bacteria were disrupted mechanically by agitation with lysing matrix B in 2-ml tubes (DBA Italia) using a homogenizer (FastPrep-24; MP Biomedicals) for 60 s at 6.5 m/s for two cycles, and kept on ice for 2 min between the cycles. Samples were then centrifuged for 5 min at 8,000 × *g*, 4°C, and RNA was extracted with a Direct-zol RNA miniprep kit (Zymo Research) according to the manufacturer's instructions. RNA samples were treated with DNase (Roche) for 2 h at 37°C and further purified using the RNeasy minikit (Qiagen), including a second DNase treatment on the column for 30 min at room temperature, according to the manufacturer's instructions. Five micrograms of pooled RNA from each triplicate was labeled (Cy5-dCTP/Cy3-dCTP; Euroclone) and purified (Wizard SV gel and PCR clean-up system; Promega). Labeled RNA from the three independent days of RNA extraction was then pooled and used for microarray analysis. Labeling, chip hybridization, washing, scanning, and data extraction were performed according to the procedures described by Agilent for two-color microarray-based gene expression analysis. After data acquisition, slide normalization was performed by a lowess (locally weighted scatterplot smoothing) algorithm, as implemented by the Agilent Feature Extraction software, version 9.5.3. The average log ratio of fluorescence signals \[log~2~(Cy5/Cy3)\] of probes corresponding to the same gene was computed within each slide. Student's *t* test statistics were performed to test for differentially expressed genes.

qRT-PCR analysis. {#h3.5}
-----------------

cDNA was prepared using the reverse transcription system (Promega) by using 500 ng of RNA per reaction mixture volume. Real-time quantitative PCR (qRT-PCR) was performed on 50 ng of cDNA that was amplified using LightCycler 480 DNA SYBR green I master (Roche). Reactions were monitored using a LightCycler 480 instrument and software (Roche). The transcript amounts under each condition were standardized to the transcription of an internal control gene (*gyrA*) and compared with standardized expression in the wild-type strain (cycle threshold \[ΔΔ*C*~*T*~\] method). Validation of microarray data by qRT-PCR was performed on a selection of 9 genes differentially expressed in mutant strains, using the RNA prepared for microarray analysis (see above) and primers reported in [Table S1](#tabS1){ref-type="supplementary-material"} in the supplemental material. Moreover, we prepared new RNA samples from WT, knockout, and complemented strains (three biological replicates obtained on three different days) to generate cDNA for qRT-PCR confirmation of highly regulated genes.

For RNA extraction from bacteria grown with different carbon sources, strains were first inoculated into CDM and grown at 37°C until an OD~600~ of 0.5 was reached. Cultures were harvested by centrifuging at 4,000 × *g*, 4°C, for 10 min, and each pellet was resuspended in 10 ml of CDM without glucose and split in two. Each 5-ml sample was then supplemented with 10 mg/ml of glucose or fructose-6-phosphate. The bacteria were then incubated for 30 min at 37°C, and RNA was extracted as described for the microarray analysis.

Bacterial lysate was obtained from a 10-ml culture of the WT strain in late logarithmic phase (OD of 1). Briefly, bacteria resuspended in PBS were disrupted mechanically by agitation with lysing matrix B in 2-ml tubes (DBA Italia) using a homogenizer (FastPrep-24) for 60 s at 6.5 m/s for four cycles. The tubes were kept on ice for 2 min between the cycles. Samples were centrifuged for 5 min at 8,000 × *g*, 4°C, and the supernatant was collected and designated as lysate. For the RNA extraction, strains were grown in CDM until reaching an OD~600~ of 0.5, harvested, split in two, and resuspended in 5 ml of CDM without glucose. Each sample was supplemented with 800 µl of PBS or with 800 µl of lysate for 30 min at 37°C before RNA extraction.

Phenotype microarray analysis. {#h3.6}
------------------------------

Phenotype microarray (PM) technology uses the irreversible chemical reduction of a patented dye as a reporter of active metabolism ([@B45]). The CJB111, Δ*rr16*, and ΚI*rr16* strains were used with microplates PM1 and PM2A (Biolog), testing 192 different single carbon sources. Bacteria on THB agar plates were scraped off and suspended in 5 ml of inoculation fluid (IF-0; Biolog) to an OD of 0.3. Samples were then diluted 1:10 in IF-0 to obtain a turbidity of 85% (OD of \~0.02 to 0.03) and kept on ice. Growth medium constituents were prepared according to Biolog's procedures for *S. agalactiae* and other *Streptococcus* species. PM microplates were inoculated by adding 100 µl bacterial suspension/well and then incubated for 48 h at 37°C in an OmniLog reader (Biolog). Data points were collected every 15 min. Data were then analyzed using the OmniLog software. The unspecific background (well A1 in each plate, negative control) was subtracted from the other samples.

In vivo and in vitro infection experiments. {#h3.7}
-------------------------------------------

Animal studies were approved by the Office of Lab Animal Care at San Diego State University and conducted under accepted veterinary standards. Animal experiments were performed in compliance with the Novartis Animal Health and Welfare guidelines.

We adopted a previously described murine model of hematogenous GBS meningitis ([@B28]), with the difference that preliminary dose-ranging experiments established the 50% lethal dose (LD~50~) dose of CJB111 as 1.5 × 10^7^ CFU per mouse (outbred 6-week-old male CD1 mice; Charles River Laboratories). The mice were followed for 2 weeks. Also, since histopathology was not performed, we considered the experiment a model of systemic infection.

The *in vivo* mouse model of GBS vaginal colonization has been described previously ([@B26]). Female CD1 mice (8 to 16 weeks old) were obtained from Charles River Laboratories and used for colonization assays. *In vitro* adhesion was performed as previously described ([@B26]) using the immortalized human vaginal epithelial cell line VK2/E6E7, obtained from the American Type Culture Collection (ATCC CRL-2616) ([@B46]). Five to 10 passages were used for all cell assays. Cells were maintained at 37°C in a 5% CO~2~ atmosphere in keratinocyte serum-free medium (KSFM; Invitrogen).

Microarray data accession numbers. {#h3.8}
----------------------------------

The microarray chip layout was submitted to EBI ArrayExpress and is available under accession number A-MEXP-2382. Experimental results are available under accession number E-MTAB-2423.
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Distribution of TCS-17 protein variants for SAM1896 (the HK) and SAM1897 (the RR). Specific polypeptide variants are indicated by numbers. Also included in the analysis are strains where the proteins are absent (Abs) or where the genome sequence presents ambiguous areas (Amb; e.g., contig breaks) and where a stop codon (Stop) terminates the polypeptide. Download
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Figure S1, EPS file, 0.1 MB
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qRT-PCR analysis of selected TCS in four different phases of growth, early (EL), mid- (ML), and late logarithmic (LL) phases and early stationary (ES) phase. Each bar represents three biological replicates, and error bars show the standard errors of the means. Fold change is relative to the expression level of each system in EL phase. Download
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Growth curves of WT and isogenic mutant strains in THB medium. Curves represent the means of triplicate samples. Download
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Correlation between microarray and qRT-PCR. Values obtained for the two methods were plotted on the *x* and *y* axes. Each dot represents the fold change of mutant versus WT for a highly regulated gene, indicated with an arrow. The mutant strains used were Δ*rr2* (red), Δ*rr11* (green), and Δ*rr16* (blue) strains. Download
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Phenotype microarray analysis on WT, Δ*rr16*, and KI*rr16* strains was performed using PM1 and PM2A plates (<http://www.biolog.com/pdf/pm_lit/PM1-PM10.pdf>). Kinetic plots are shown in red (WT) or in green (mutant and complemented strains), and superimposition is shown in yellow. Metabolic differences between WT and Δ*rr16* mutant or WT and KI*rr16* mutant are shown in superimposed kinetic plots obtained by growing bacteria on PM1 (A and **C**) or PM2A (B and D). Download
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Oligonucleotides used in this study.
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Table S1, DOC file, 0.1 MB.
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